Latest Commercialisation News

AdAlta Limited outlines its innovative 'East to West' cellular immunotherapy approach, in-licensing Asian CAR-T assets and progressing clinical trials in Australia to unlock value. The company also seeks partners for its anti-fibrotic and anti-malarial protein therapeutics.

Amplitude Energy has delivered record production and earnings in FY25, driven by operational improvements and a strategic joint venture for the East Coast Supply Project.

Bass Oil reported steady oil production in July alongside progress in acquiring the Vanessa gas field and advancing deep coal commercialisation efforts.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Kinetiko Energy reports a peak gas flow rate of 370 Mscfd from its optimised drilling at the Brakfontein well 271-KA03PT10, advancing its South African gas project.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

Triangle Energy and Athena Exploration have significantly upgraded gas resource estimates for the UK P2628 permit, positioning themselves among the top undeveloped gas holders in the region.

Botala Energy has raised A$1.5 million through a discounted share placement to fund critical drilling and feasibility work at its Serowe CBM Project in Botswana. Directors and the CEO are backing the raise, signaling confidence in the project’s potential.

AML3D Limited reported a modest increase in revenue for FY2025 but saw its losses widen significantly, raising questions about its path to profitability.

Silex Systems Limited has announced a Share Purchase Plan (SPP) aiming to raise up to $15 million, offering existing eligible shareholders new shares at a price capped at $3.90 or a 2% discount to recent trading prices. This follows a $130 million institutional placement and supports key commercialisation projects in uranium enrichment.

dorsaVi Ltd has raised A$5 million through a strategic placement to accelerate development of its next-generation RRAM-enabled sensors and robotics platforms, signaling a bold expansion into edge AI and neuromorphic computing.

HyTerra Limited’s McCoy 1 well in Kansas has confirmed significant concentrations of geologic hydrogen and helium, advancing the company’s exploration ambitions with appraisal activities now underway.